Discovery of HDM2004, a potent, selective and orally bioavailable HPK1 inhibitor for tumor immunotherapy.

Zhang Z, Huang M, E J, Zhang Z, Deng T, Yang Y, Sun Y, Zou J, Zhang X, Chen T, Liu D.

Open source

DOI
10.1016/j.ejmech.2026.118708
Published
2026-02-20
Container
Eur J Med Chem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.118708,
  title = {Discovery of HDM2004, a potent, selective and orally bioavailable HPK1 inhibitor for tumor immunotherapy.},
  author = {Zhang Z and  Huang M and  E J and  Zhang Z and  Deng T and  Yang Y and  Sun Y and  Zou J and  Zhang X and  Chen T and  Liu D.},
  year = {2026},
  journal = {Eur J Med Chem},
  doi = {10.1016/j.ejmech.2026.118708},
  url = {https://doi.org/10.1016/j.ejmech.2026.118708}
}

RIS

TY  - JOUR
TI  - Discovery of HDM2004, a potent, selective and orally bioavailable HPK1 inhibitor for tumor immunotherapy.
AU  - Zhang Z
AU  -  Huang M
AU  -  E J
AU  -  Zhang Z
AU  -  Deng T
AU  -  Yang Y
AU  -  Sun Y
AU  -  Zou J
AU  -  Zhang X
AU  -  Chen T
AU  -  Liu D.
PY  - 2026
JO  - Eur J Med Chem
DO  - 10.1016/j.ejmech.2026.118708
UR  - https://doi.org/10.1016/j.ejmech.2026.118708
ER  -

APA

Z, Z., M, H., J, E., Z, Z., T, D., Y, Y., Y, S., J, Z., X, Z., T, C., & D., L. (2026). Discovery of HDM2004, a potent, selective and orally bioavailable HPK1 inhibitor for tumor immunotherapy.. Eur J Med Chem. https://doi.org/10.1016/j.ejmech.2026.118708

Source records